Kaat Desloovere Selected Research

Cerebral Palsy (Spastic Diplegia)

1/2022	Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.
1/2020	Tone Reduction and Physical Therapy: Strengthening Partners in Treatment of Children with Spastic Cerebral Palsy.
1/2020	Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation.
1/2020	Effects of combining constraint-induced movement therapy and action-observation training on upper limb kinematics in children with unilateral cerebral palsy: a randomized controlled trial.
1/2020	Joint and Muscle Assessments of the Separate Effects of Botulinum NeuroToxin-A and Lower-Leg Casting in Children With Cerebral Palsy.
10/2019	Role of femoral derotation on gait after selective dorsal rhizotomy in children with spastic cerebral palsy.
1/2019	Selective dorsal rhizotomy improves muscle forces during walking in children with spastic cerebral palsy.
1/2019	Muscle synergies demonstrate only minimal changes after treatment in cerebral palsy.
1/2019	Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
11/2018	Associations Between Muscle Synergies and Treatment Outcomes in Cerebral Palsy Are Robust Across Clinical Centers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaat Desloovere Research Topics

Disease

32	Cerebral Palsy (Spastic Diplegia) 01/2022 - 01/2006
5	Muscle Spasticity (Spastic) 01/2020 - 02/2017
3	Stroke (Strokes) 01/2019 - 08/2016
3	Hemiplegia (Spastic Hemiplegia) 01/2008 - 10/2006
2	Seizures (Absence Seizure) 11/2021 - 01/2021
2	Brain Diseases (Brain Disorder) 11/2021 - 01/2021
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 11/2021 - 01/2021
2	Hip Osteoarthritis (Coxarthrosis) 01/2018 - 11/2016
2	Movement Disorders (Movement Disorder) 01/2010 - 09/2006
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Congenital Abnormalities (Deformity) 01/2021
1	Muscle Weakness 01/2020
1	Paresis (Hemiparesis) 01/2017
1	Knee Osteoarthritis 10/2016
1	Motor Neuron Disease (Primary Lateral Sclerosis) 08/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2016
1	Osteoarthritis 10/2014
1	Pain (Aches) 11/2013

Drug/Important Bio-Agent (IBA)

13	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 01/2006
5	Botulinum Toxins (Botulinum Toxin)IBA 01/2016 - 09/2006
4	incobotulinumtoxinA FDA Link 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 11/2021 - 01/2021
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2017
2	Carbon Fiber (Grafil)IBA 01/2008 - 10/2006
1	DystrophinIBA 01/2022
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2017
1	AntibodiesIBA 09/2009

Therapy/Procedure

7	Injections 01/2022 - 01/2007
5	Physical Therapy Modalities (Physical Therapy Technique) 01/2020 - 01/2006
4	Therapeutics 01/2020 - 05/2012
2	Resistance Training 01/2021 - 01/2020
2	Rhizotomy 10/2019 - 01/2019
2	Aftercare (After-Treatment) 01/2019 - 11/2018
2	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2018 - 11/2016
2	Foot Orthoses 01/2008 - 10/2006
2	Orthotic Devices (Orthosis) 01/2008 - 10/2006
1	Tenotomy 10/2018
1	Muscle Stretching Exercises (Stretching, Static) 01/2018
1	Orthopedic Procedures 02/2017
1	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2016
1	Surgical Amputation (Amputations) 08/2016
1	Arthroplasty 10/2014
1	Splints (Splint) 01/2008
1	Treatment Delay 01/2006
1	Operative Surgical Procedures 01/2006